renografin-60
Renografin-60 is a combination medicine containing Diatrizoate Meglumine and Diatrizoate Sodium.
Diatrizoate Meglumine and Diatrizoate Sodium · by Bracco
Every strength approved under this FDA application (2)
- Renografin-60 (this page)Diatrizoate Meglumine 52%; Diatrizoate Sodium 8%
- Renografin-76Diatrizoate Meglumine 66%; Diatrizoate Sodium 10%
Key facts
What is Renografin-60?
From the FDA label:Cystografin is a radiopaque contrast agent supplied as a sterile, clear, colorless to pale yellow, mobile or slightly viscous solution. Each mL provides 300 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of solution also contains approximately 141 mg organically bound iodine. At the time of manufacture, the air in the container is replaced by nitrogen. The preparation should be protected from strong light.
How to use
Preparation of the patient: Appropriate preparation is desirable for optimal results. A laxative the night before the examination and a low residue diet the day before the procedure are recommended. Dosage: The dose for retrograde use in cystography and voiding cystourethrography ranges from 25 to 300 mL depending on the age of the patient and the degree of bladder irritability; amounts greater than 300 mL may be used if the bladder capacity allows. Best results are obtained when the bladder is filled with the contrast agent. If desired, the preparation may be diluted with sterile water or sterile saline as indicated in the table below. Administration: After sterile catheterization, the bladder should be filled to capacity with Cystografin using a suitable sterile administration set. Care should be taken to avoid using excessive pressure. The presence of bladder discomfort or reflux and/or spontaneous voiding usually indicates that the bladder is full. Radiography: The commonly employed radiographic techniques should be used. A scout film is recommended before the contrast agent is administered. Dilution Table USE DILUTED SOLUTIONS IMMEDIATELY 100 mL Bottle Sterile Water or Sterile Saline Added % Diatrizoate Meglumine w/v % Organically Bound Iodine w/v Total Volume 0 mL 30.0 14.1 100 mL 25 mL 24.0 11.3 125 mL 50 mL 20.0 9.4 150 mL 67 mL 18.0 8.5 167 mL 300 mL Bottle Sterile…
Side effects
Retrograde genitourinary procedures may cause such complications as hematuria, perforation of the urethra or bladder, introduction of infection into the genitourinary tract, and oliguria or anuria. If intravasation of this drug occurs, the reactions which may be associated with intravenous administration may possibly be encountered. Hypersensitivity or anaphylactoid reactions may occur. Severe reactions may be manifested by edema of the face and glottis, respiratory distress, convulsions or shock; such reactions may prove fatal unless promptly controlled by such emergency measures as maintenance of a clear airway and immediate use of oxygen and resuscitative drugs. Endocrine: Thyroid function tests indicative of hypothyroidism or transient thyroid suppression have been uncommonly reported following iodinated contrast media administration to adult and pediatric patients, including infants. Some patients were treated for hypothyroidism.
Warnings
Important safety information
Severe sensitivity reactions are more likely to occur in patients with a personal or family history of bronchial asthma, significant allergies, or previous reactions to contrast agents. A history of sensitivity to iodine per se or to other contrast agents is not an absolute contraindication to the use of diatrizoate meglumine, but calls for extreme caution in administration.
Who should not take Renografin-60
This preparation is contraindicated in patients with a hypersensitivity to salts of diatrizoic acid.
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- Is there a coupon or discount for Renografin-60?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Renografin-60. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Renografin-60?
- Renografin-60 is marketed by Bracco. You can see Bracco's full profile, rating, and other products on pharmaranks.
- Is Renografin-60 a brand-name or generic drug?
- Renografin-60 is a brand-name product with the active ingredient Diatrizoate Meglumine and Diatrizoate Sodium.
- Is Renografin-60 available over the counter?
- No. Renografin-60 is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Renografin-60 come in?
- Renografin-60 is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Renografin-60 FDA-registered?
- Renografin-60 is on record with the U.S. FDA under application number NDA010040. You can verify this on its official FDA label.
- Is Renografin-60 safe?
- There's no single safe-or-not verdict, and we don't yet have a composite recall-safety score for Renografin-60. Review its FDA-label side effects and warnings below, and always consult a licensed professional.
- What are the side effects of Renografin-60?
- Renografin-60's side effects are taken directly from its FDA label. From the label: Retrograde genitourinary procedures may cause such complications as hematuria, perforation of the urethra or bladder, introduction of infection into the genitourinary tract, and oliguria or anuria. If intravasation of this drug occurs,… Both common and serious reactions are documented in full on this page. This is general reference from the FDA, not medical advice — always consult a professional.
Clinical content sourced from the FDA label via openFDA (U.S. FDA). View the FDA label on DailyMed → Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
cystografin
Diatrizoate Meglumine and Diatrizoate Sodium
cystografin dilute
Diatrizoate Meglumine and Diatrizoate Sodium
gastrografin
Diatrizoate Meglumine and Diatrizoate Sodium
reno-30
Diatrizoate Meglumine and Diatrizoate Sodium
reno-60
Diatrizoate Meglumine and Diatrizoate Sodium
reno-dip
Diatrizoate Meglumine and Diatrizoate Sodium
Compare Renografin-60 head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
renografin-60
New